The arrhythmia market size has grown strongly in recent years. It will grow from $8.28 billion in 2025 to $9.03 billion in 2026 at a compound annual growth rate (CAGR) of 9%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, rising aging population, improved availability of diagnostic cardiac devices, growing awareness of heart rhythm disorders, expansion of hospital cardiology departments.
The arrhythmia market size is expected to see strong growth in the next few years. It will grow to $12.65 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing adoption of remote patient monitoring solutions, rising investments in digital cardiology platforms, growing demand for early-stage arrhythmia detection, expansion of home-based cardiac care, technological advancements in cardiac diagnostics. Major trends in the forecast period include increasing adoption of ai-based arrhythmia detection tools, rising use of wearable and remote cardiac monitoring devices, growing integration of digital ecg and holter technologies, expansion of personalized arrhythmia treatment approaches, enhanced focus on early diagnosis and continuous monitoring.
The increasing prevalence of cardiac disease and other heart-related conditions is anticipated to drive the expansion of the arrhythmia market in the coming years. Cardiac disease, also known as cardiovascular disease, encompasses a broad range of disorders affecting the heart and blood vessels, including conditions such as atherosclerosis, heart attack, stroke, and arrhythmia, among others. Both functional abnormalities, such as diastolic and systolic dysfunction, and electrical abnormalities, including the onset of arrhythmias, contribute to a higher incidence of heart failure, atrial fibrillation, and other cardiovascular disorders. For example, in October 2024, according to the Centers for Disease Control and Prevention, a United States-based government agency, cardiovascular disease was responsible for 919,032 deaths in 2023, representing nearly one in every three deaths. Coronary heart disease remained the most common form of heart disease, and notably, approximately one in six cardiovascular disease-related deaths occurred among adults under the age of 65. Therefore, the growing burden of cardiac disease and other heart problems is fueling the growth of the arrhythmia market.
Prominent entities within the arrhythmia market are actively engaged in the development of cutting-edge catheters to fortify their positions within the industry. Catheters, being slender, flexible tube-like medical devices, play diverse roles such as extracting fluids from body cavities, administering fluids or medications, or measuring various parameters within the body. For instance, in July 2023, Biosense Webster, Inc., a US-based medical equipment manufacturer, unveiled the Optrell Mapping Catheter, incorporating TrueRef Technology, engineered to assist electrophysiologists in mapping intricate cardiac arrhythmias. This catheter integrates a fixed array of small electrodes, enabling high-definition mapping for conditions like atrial fibrillation and tachycardia. Specifically designed for compatibility with the Carto 3 system developed by Biosense Webster, this catheter expedites the identification of ablation targets with enhanced efficiency and accuracy. By providing heightened diagnostic insights, it significantly boosts confidence in detecting ablation targets even within the most complex cases, marking a substantial advancement in the realm of cardiac electrophysiology.
In November 2024, Boston Scientific Corporation, a United States-based healthcare technology company, acquired Cortex Inc. for an undisclosed amount. Through this acquisition, Boston Scientific seeks to expand its neurovascular device portfolio and enhance its expertise in minimally invasive therapies for cerebrovascular conditions. Cortex Inc. is a United States-based healthcare technology company focused on the development of advanced neurovascular medical devices, including stents and delivery systems, designed to treat complex brain aneurysms and other vascular disorders.
Major companies operating in the arrhythmia market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, AliveCor Inc., Biotronik SE & Co. KG, Biotricity Inc., GE Healthcare, Koninklijke Philips N.V., Nihon Kohden Corporation, Spacelabs Healthcare, Welch Allyn Inc., Mylan N.V., Lepu Medical Technology Co. Ltd., iRhythm Technologies Inc., BioTelemetry Inc., Fukuda Denshi Co. Ltd., Smart Solutions Technologies Inc., Biosense Webster Inc., Cardiac Science Corporation, CardioComm Solutions Inc., CardioNet LLC, NUUBO SMART SOLUTIONS S.L., Cardiva Medical Inc., Osypka AG, Johnson & Johnson Services Inc., Pfizer Inc, Teva Pharmaceutical Industries Ltd, Applied Cardiac Systems, Acutus Medical, EP Solutions SA.
North America was the largest region in the arrhythmia market in 2025. The regions covered in the arrhythmia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the arrhythmia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the arrhythmia market by increasing costs of imported diagnostic equipment, wearable sensors, monitoring electronics, and medical-grade semiconductors used in ECG and Holter systems. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported medical devices, while Asia-Pacific faces cost pressures on manufacturing and exports. These tariffs are increasing device procurement costs and slowing technology upgrades. However, they are also encouraging local device manufacturing, regional sourcing of components, and innovation in cost-effective cardiac monitoring solutions.
The arrhythmia market research report is one of a series of new reports that provides arrhythmia market statistics, including arrhythmia industry global market size, regional shares, competitors with a arrhythmia market share, detailed arrhythmia market segments, market trends and opportunities, and any further data you may need to thrive in the arrhythmia industry. This arrhythmia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Arrhythmia is a heart disorder characterized by an abnormality in the normal sequence of electrical impulses, leading to changes in the rate or rhythm at which the heart beats. This can result in the electrical impulses being too fast, too slow, or occurring erratically, leading to irregular heartbeats.
The main types of arrhythmias include supraventricular tachycardias, ventricular arrhythmias, bradyarrhythmias, and others. Supraventricular tachycardias involve a condition where the heart suddenly beats much faster than normal, followed by an abrupt slowing down. Various diagnostic tools, such as an electrocardiogram (ECG) and holter monitor, can be employed to test for arrhythmias. These tests can detect different degrees of heart blocks, including first-degree, second-degree, and third-degree blocks. Arrhythmia-related services are typically provided through various distribution channels, including hospital pharmacies, retail pharmacies, and online pharmacies.
The arrhythmia market includes revenues earned by entities from sinus bradycardia, premature atrial contractions (PACS), wandering atrial pacemakers, atrial tachycardia, multifocal atrial tachycardia, atrial flutter, and atrial fibrillation (AFIB). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The arrhythmia market size is expected to see strong growth in the next few years. It will grow to $12.65 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing adoption of remote patient monitoring solutions, rising investments in digital cardiology platforms, growing demand for early-stage arrhythmia detection, expansion of home-based cardiac care, technological advancements in cardiac diagnostics. Major trends in the forecast period include increasing adoption of ai-based arrhythmia detection tools, rising use of wearable and remote cardiac monitoring devices, growing integration of digital ecg and holter technologies, expansion of personalized arrhythmia treatment approaches, enhanced focus on early diagnosis and continuous monitoring.
The increasing prevalence of cardiac disease and other heart-related conditions is anticipated to drive the expansion of the arrhythmia market in the coming years. Cardiac disease, also known as cardiovascular disease, encompasses a broad range of disorders affecting the heart and blood vessels, including conditions such as atherosclerosis, heart attack, stroke, and arrhythmia, among others. Both functional abnormalities, such as diastolic and systolic dysfunction, and electrical abnormalities, including the onset of arrhythmias, contribute to a higher incidence of heart failure, atrial fibrillation, and other cardiovascular disorders. For example, in October 2024, according to the Centers for Disease Control and Prevention, a United States-based government agency, cardiovascular disease was responsible for 919,032 deaths in 2023, representing nearly one in every three deaths. Coronary heart disease remained the most common form of heart disease, and notably, approximately one in six cardiovascular disease-related deaths occurred among adults under the age of 65. Therefore, the growing burden of cardiac disease and other heart problems is fueling the growth of the arrhythmia market.
Prominent entities within the arrhythmia market are actively engaged in the development of cutting-edge catheters to fortify their positions within the industry. Catheters, being slender, flexible tube-like medical devices, play diverse roles such as extracting fluids from body cavities, administering fluids or medications, or measuring various parameters within the body. For instance, in July 2023, Biosense Webster, Inc., a US-based medical equipment manufacturer, unveiled the Optrell Mapping Catheter, incorporating TrueRef Technology, engineered to assist electrophysiologists in mapping intricate cardiac arrhythmias. This catheter integrates a fixed array of small electrodes, enabling high-definition mapping for conditions like atrial fibrillation and tachycardia. Specifically designed for compatibility with the Carto 3 system developed by Biosense Webster, this catheter expedites the identification of ablation targets with enhanced efficiency and accuracy. By providing heightened diagnostic insights, it significantly boosts confidence in detecting ablation targets even within the most complex cases, marking a substantial advancement in the realm of cardiac electrophysiology.
In November 2024, Boston Scientific Corporation, a United States-based healthcare technology company, acquired Cortex Inc. for an undisclosed amount. Through this acquisition, Boston Scientific seeks to expand its neurovascular device portfolio and enhance its expertise in minimally invasive therapies for cerebrovascular conditions. Cortex Inc. is a United States-based healthcare technology company focused on the development of advanced neurovascular medical devices, including stents and delivery systems, designed to treat complex brain aneurysms and other vascular disorders.
Major companies operating in the arrhythmia market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, AliveCor Inc., Biotronik SE & Co. KG, Biotricity Inc., GE Healthcare, Koninklijke Philips N.V., Nihon Kohden Corporation, Spacelabs Healthcare, Welch Allyn Inc., Mylan N.V., Lepu Medical Technology Co. Ltd., iRhythm Technologies Inc., BioTelemetry Inc., Fukuda Denshi Co. Ltd., Smart Solutions Technologies Inc., Biosense Webster Inc., Cardiac Science Corporation, CardioComm Solutions Inc., CardioNet LLC, NUUBO SMART SOLUTIONS S.L., Cardiva Medical Inc., Osypka AG, Johnson & Johnson Services Inc., Pfizer Inc, Teva Pharmaceutical Industries Ltd, Applied Cardiac Systems, Acutus Medical, EP Solutions SA.
North America was the largest region in the arrhythmia market in 2025. The regions covered in the arrhythmia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the arrhythmia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the arrhythmia market by increasing costs of imported diagnostic equipment, wearable sensors, monitoring electronics, and medical-grade semiconductors used in ECG and Holter systems. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported medical devices, while Asia-Pacific faces cost pressures on manufacturing and exports. These tariffs are increasing device procurement costs and slowing technology upgrades. However, they are also encouraging local device manufacturing, regional sourcing of components, and innovation in cost-effective cardiac monitoring solutions.
The arrhythmia market research report is one of a series of new reports that provides arrhythmia market statistics, including arrhythmia industry global market size, regional shares, competitors with a arrhythmia market share, detailed arrhythmia market segments, market trends and opportunities, and any further data you may need to thrive in the arrhythmia industry. This arrhythmia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Arrhythmia is a heart disorder characterized by an abnormality in the normal sequence of electrical impulses, leading to changes in the rate or rhythm at which the heart beats. This can result in the electrical impulses being too fast, too slow, or occurring erratically, leading to irregular heartbeats.
The main types of arrhythmias include supraventricular tachycardias, ventricular arrhythmias, bradyarrhythmias, and others. Supraventricular tachycardias involve a condition where the heart suddenly beats much faster than normal, followed by an abrupt slowing down. Various diagnostic tools, such as an electrocardiogram (ECG) and holter monitor, can be employed to test for arrhythmias. These tests can detect different degrees of heart blocks, including first-degree, second-degree, and third-degree blocks. Arrhythmia-related services are typically provided through various distribution channels, including hospital pharmacies, retail pharmacies, and online pharmacies.
The arrhythmia market includes revenues earned by entities from sinus bradycardia, premature atrial contractions (PACS), wandering atrial pacemakers, atrial tachycardia, multifocal atrial tachycardia, atrial flutter, and atrial fibrillation (AFIB). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Arrhythmia Market Characteristics
3. Arrhythmia Market Supply Chain Analysis
4. Global Arrhythmia Market Trends and Strategies
5. Arrhythmia Market Analysis of End Use Industries
7. Global Arrhythmia Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Arrhythmia Total Addressable Market (TAM) Analysis for the Market
9. Arrhythmia Market Segmentation
10. Arrhythmia Market Regional and Country Analysis
11. Asia-Pacific Arrhythmia Market
12. China Arrhythmia Market
13. India Arrhythmia Market
14. Japan Arrhythmia Market
15. Australia Arrhythmia Market
16. Indonesia Arrhythmia Market
17. South Korea Arrhythmia Market
18. Taiwan Arrhythmia Market
19. South East Asia Arrhythmia Market
20. Western Europe Arrhythmia Market
21. UK Arrhythmia Market
22. Germany Arrhythmia Market
23. France Arrhythmia Market
24. Italy Arrhythmia Market
25. Spain Arrhythmia Market
26. Eastern Europe Arrhythmia Market
27. Russia Arrhythmia Market
28. North America Arrhythmia Market
29. USA Arrhythmia Market
30. Canada Arrhythmia Market
31. South America Arrhythmia Market
32. Brazil Arrhythmia Market
33. Middle East Arrhythmia Market
34. Africa Arrhythmia Market
36. Arrhythmia Market Competitive Landscape and Company Profiles
37. Arrhythmia Market Other Major and Innovative Companies
40. Arrhythmia Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Arrhythmia Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses arrhythmia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for arrhythmia? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The arrhythmia market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Supraventricular Tachycardias; Ventricular Arrhythmias; Bradyarrhythmias; Other Types2) By Test Equipment: Electrocardiogram (ECG); Holter Monitor
3) By Hearth Blocks: First Degree Heart Block; Second Degree Heart Block; Third Degree Heart Block
4) By Distribution Channel: Hospitals Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Supraventricular Tachycardias: Atrial Fibrillation; Atrial Flutter; Paroxysmal Supraventricular Tachycardia (PSVT)2) By Ventricular Arrhythmias: Ventricular Fibrillation; Ventricular Tachycardia; Premature Ventricular Contractions (PVCs)
3) By Bradyarrhythmias: Sinus Bradycardia; Heart Block
4) By Other Types: Long QT Syndrome; Wolff-Parkinson-White Syndrome; Torsades de Pointes
Companies Mentioned: Medtronic PLC; Abbott Laboratories; Boston Scientific Corporation; AliveCor Inc.; Biotronik SE & Co. KG; Biotricity Inc.; GE Healthcare; Koninklijke Philips N.V.; Nihon Kohden Corporation; Spacelabs Healthcare; Welch Allyn Inc.; Mylan N.V.; Lepu Medical Technology Co. Ltd.; iRhythm Technologies Inc.; BioTelemetry Inc.; Fukuda Denshi Co. Ltd.; Smart Solutions Technologies Inc.; Biosense Webster Inc.; Cardiac Science Corporation; CardioComm Solutions Inc.; CardioNet LLC; NUUBO SMART SOLUTIONS S.L.; Cardiva Medical Inc.; Osypka AG; Johnson & Johnson Services Inc.; Pfizer Inc; Teva Pharmaceutical Industries Ltd; Applied Cardiac Systems; Acutus Medical; EP Solutions SA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Arrhythmia market report include:- Medtronic PLC
- Abbott Laboratories
- Boston Scientific Corporation
- AliveCor Inc.
- Biotronik SE & Co. KG
- Biotricity Inc.
- GE Healthcare
- Koninklijke Philips N.V.
- Nihon Kohden Corporation
- Spacelabs Healthcare
- Welch Allyn Inc.
- Mylan N.V.
- Lepu Medical Technology Co. Ltd.
- iRhythm Technologies Inc.
- BioTelemetry Inc.
- Fukuda Denshi Co. Ltd.
- Smart Solutions Technologies Inc.
- Biosense Webster Inc.
- Cardiac Science Corporation
- CardioComm Solutions Inc.
- CardioNet LLC
- NUUBO SMART SOLUTIONS S.L.
- Cardiva Medical Inc.
- Osypka AG
- Johnson & Johnson Services Inc.
- Pfizer Inc
- Teva Pharmaceutical Industries Ltd
- Applied Cardiac Systems
- Acutus Medical
- EP Solutions SA
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 9.03 Billion |
| Forecasted Market Value ( USD | $ 12.65 Billion |
| Compound Annual Growth Rate | 8.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |
